Quince Therapeutics publishes eDSP study data in pulmonary, IBD disorders

Go back to Quince Therapeutics publishes eDSP study data in pulmonary, IBD disorders
(NASDAQ: QNCX) Delayed: 31.73 --0 (-0%)
Previous Close $31.73    52 Week High $ 
Open $31.73    52 Week Low $ 
Day High $31.73    P/E N/A 
Day Low $31.73    EPS $ 
Volume 13,591